Nextdoor Holdings' share price reflects its promising future growth. However, other factors like its balance sheet strength should be considered, especially as the stock trades around its fair value. The company's positive outlook is encouraging for potential investors.
Investors may be overvaluing Nextdoor Holdings given its high P/S ratio and weak projected revenue growth. This could risk share price decline or investors paying an unwarranted premium.
Despite Nextdoor's promising growth outlook, its overvalued stock suggests it may not be the best time for potential investors to buy. Current shareholders may want to consider selling.
In view of the weaker than expected recovery in the ad market, particularly in the financial services and home services vertical markets, CEO Sarah Friar deems the job cuts necessary to 'right-size' the business, despite the tough decision.
The quarter's results showed slowing growth and missed estimates, leading to a negative view. The downturn is seen by some as an investment opportunity, whereas others urge caution due to concerns about the company's valuation, business qualities, and recent quarterly results. Total Weekly Active Users (WAU) miss was a notable worry.
Nextdoor Holdings股票討論區
In reaction to earnings/guidance:
• $Wolfspeed(WOLF.US)$ +22.2%, $阿特斯太陽能(CSIQ.US)$ +6.5%, $BJ批發俱樂部(BJ.US)$ +5.8%, $思科(CSCO.US)$ +5.3%, $Keysight Technologies(KEYS.US)$ +4.3%, $麥迪森運動(MSGS.US)$ +3%, $網易(NTES.US)$ +2.7%, $NICE Ltd(NICE.US)$ +2.1%, $新思科技(SNPS.US)$ + 1.8%
News:
• $Brooge Energy(BROG.US)$ +17.1% (says majority shareholder, BPGIC Holdings, would like to take ...
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US)$+17%, $Workiva(WK.US)$ +15.3%, $Arlo Technologies(ARLO.US)$ +12%, $Array Technologies(ARRY.US)$ +10.3%, $Everbridge(EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals(CPRX.US)$ +9.4%, $奧洛茲美醫療(HALO.US)$ +8.7%, $Velo3D(VLD.US)$ +7.6%, $CyberArk(CYBR.US)$ + 6.2%, $美國血液技術(HAE.US)$ +5.8%, $Jackson Financial(JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise(AXON.US)$ +4.8%,...
• $Repare Therapeutics(RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy(CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath(PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage(PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology(CRDO.US)$ +10.2% (In reaction ...
暫無評論